| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |